High-throughput screening assays for the identification of chemical probes.

High-throughput screening (HTS) assays enable the testing of large numbers of chemical substances for activity in diverse areas of biology. The biological responses measured in HTS assays span isolated biochemical systems containing purified receptors or enzymes to signal transduction pathways and complex networks functioning in cellular environments. This Review addresses factors that need to be considered when implementing assays for HTS and is aimed particularly at investigators new to this field. We discuss assay design strategies, the major detection technologies and examples of HTS assays for common target classes, cellular pathways and simple cellular phenotypes. We conclude with special considerations for configuring sensitive, robust, informative and economically feasible HTS assays.

[1]  R. Duggal,et al.  Development of a Novel Dicistronic Reporter-Selectable Hepatitis C Virus Replicon Suitable for High-Throughput Inhibitor Screening , 2006, Antimicrobial Agents and Chemotherapy.

[2]  D. Jameson,et al.  Fluorescence polarization: past, present and future. , 2003, Combinatorial chemistry & high throughput screening.

[3]  P. Broad,et al.  Identification of kinase inhibitors by an ATP depletion method. , 2004, Assay and drug development technologies.

[4]  T. Nordström,et al.  Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells. , 2001, Analytical biochemistry.

[5]  Steven Anderson,et al.  Dual-laser fluorescence correlation spectroscopy as a biophysical probe of binding interactions: evaluation of new red fluorescent dyes , 2001, SPIE BiOS.

[6]  G. Mathis,et al.  High Throughput Screening for Human Interferon-y Production Inhibitor Using Homogenous Time-Resolved Fluorescence , 2000, Journal of biomolecular screening.

[7]  Lance G. Laing,et al.  Label-Free Assays on the BIND System , 2004, Journal of biomolecular screening.

[8]  Engaging science and technology for drug development. , 2002, Assay and drug development technologies.

[9]  P. Emmerson,et al.  Development of Displacement Binding and GTPγS Scintillation Proximity Assays for the Identification of Antagonists of the μ-Opioid Receptor , 2003 .

[10]  Edgar Jacoby,et al.  The 7 TM G‐Protein‐Coupled Receptor Target Family , 2006, ChemMedChem.

[11]  D. Mcbranch,et al.  Fluorescent-conjugated polymer superquenching facilitates highly sensitive detection of proteases. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Dominguez,et al.  High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38α Kinase Inhibitors Using Cell-Based Assays , 2006 .

[13]  L. Mayr,et al.  SpeedScreen: The “Missing Link” between Genomics and Lead Discovery , 2004, Journal of biomolecular screening.

[14]  Lee L. Rubin,et al.  Targeting the Hedgehog pathway in cancer , 2006, Nature Reviews Drug Discovery.

[15]  Helen M Blau,et al.  Enzymatic detection of protein translocation , 2005, Nature Methods.

[16]  Jay Liu,et al.  An immobilized metal ion affinity adsorption and scintillation proximity assay for receptor-stimulated phosphoinositide hydrolysis. , 2003, Analytical biochemistry.

[17]  Gerd Ulrich Nienhaus,et al.  Automated high content screening for phosphoinositide 3 kinase inhibition using an AKT 1 redistribution assay. , 2006, Combinatorial chemistry & high throughput screening.

[18]  P. Verboven,et al.  Microplate differential calorimetric biosensor for ascorbic acid analysis in food and pharmaceuticals. , 2007, Analytical chemistry.

[19]  M. Eigen,et al.  Rapid assay processing by integration of dual-color fluorescence cross-correlation spectroscopy: high throughput screening for enzyme activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Stephen W Michnick,et al.  Chemical genetic strategies to delineate MAP kinase signaling pathways using protein-fragment complementation assays (PCA). , 2006, Methods.

[21]  A. Sanfridson,et al.  Inflammatory pathway analysis using a high content screening platform. , 2005, Assay and drug development technologies.

[22]  P. Wylie,et al.  Application of laser-scanning fluorescence microplate cytometry in high content screening. , 2006, Assay and drug development technologies.

[23]  Kewei Wang,et al.  Rb+ efflux through functional activation of cardiac KCNQ1/minK channels by the benzodiazepine R-L3 (L-364,373). , 2006, Assay and drug development technologies.

[24]  Anthony G. Frutos,et al.  Label-Free High-Throughput Functional Lytic Assays , 2007, Journal of biomolecular screening.

[25]  E. Sterchi,et al.  Proteolytic enzymes : tools and targets , 1999 .

[26]  J. Pin,et al.  D-myo-inositol 1-phosphate as a surrogate of D-myo-inositol 1,4,5-tris phosphate to monitor G protein-coupled receptor activation. , 2006, Analytical biochemistry.

[27]  Yue Yuan,et al.  Determining Appropriate Substrate Conversion for Enzymatic Assays in High-Throughput Screening , 2003, Journal of biomolecular screening.

[28]  Jing Zhang,et al.  High-content screening moves to the front of the line. , 2006, Drug discovery today.

[29]  Robert A Copeland,et al.  Mechanistic considerations in high-throughput screening. , 2003, Analytical biochemistry.

[30]  M. Ferrer,et al.  A PDZ domain-based detection system for enzymatic assays. , 2002, Analytical biochemistry.

[31]  C. M. Flores,et al.  A nonadherent cell-based HTS assay for N-type calcium channel using calcium 3 dye. , 2006, Assay and drug development technologies.

[32]  A. Pope.  Introduction LANCE™ vs. HTRF® Technologies (or Vice Versa) , 1999 .

[33]  B. K. Lundholt,et al.  A simple cell-based HTS assay system to screen for inhibitors of p53-Hdm2 protein-protein interactions. , 2006, Assay and drug development technologies.

[34]  Y. Wong,et al.  Gα 16/z Chimeras Efficiently Link a Wide Range of G Protein— Coupled Receptors to Calcium Mobilization , 2003, Journal of biomolecular screening.

[35]  K. Eidne,et al.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.

[36]  Alison J. Smith,et al.  A morphology- and kinetics-based cascade for human neural cell high content screening. , 2006, Assay and drug development technologies.

[37]  J. Owicki,et al.  Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer , 2000, Journal of biomolecular screening.

[38]  R. Lowery,et al.  Transcreener™: screening enzymes involved in covalent regulation , 2006, Expert opinion on therapeutic targets.

[39]  P. Frost,et al.  Development and comparison of two nonradioactive kinase assays for I kappa B kinase. , 2004, Analytical biochemistry.

[40]  S. Møller,et al.  Nuclear export inhibitors and kinase inhibitors identified using a MAPK-activated protein kinase 2 redistribution screen. , 2004, Assay and drug development technologies.

[41]  T. Kenakin,et al.  Inverse, protean, and ligand‐selective agonism: matters of receptor conformation , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Wei Zheng,et al.  High throughput assay technologies for ion channel drug discovery. , 2004, Assay and drug development technologies.

[43]  R. Eglen,et al.  Galactosidase Enzyme Fragment Complementation as a High-Throughput Screening Protease Technology , 2004, Journal of biomolecular screening.

[44]  J. Hsu,et al.  Development of a cell-based assay for monitoring specific hepatitis C virus NS3/4A protease activity in mammalian cells. , 2003, Analytical biochemistry.

[45]  B. Strulovici,et al.  Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system. , 2003, Analytical biochemistry.

[46]  T. Priestley,et al.  Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen. , 2005, Assay and drug development technologies.

[47]  R. Haugland.  The Handbook: A Guide to Fluorescent Probes and Labeling Technologies , 2005 .

[48]  Sanjiv S Gambhir,et al.  Reporter gene imaging of protein-protein interactions in living subjects. , 2007, Current opinion in biotechnology.

[49]  M. Auer,et al.  Confocal fluorescence detection expanded to UV excitation: the first continuous fluorimetric assay of human steroid sulfatase in nanoliter volume. , 2004, Assay and drug development technologies.

[50]  Xiao Xu,et al.  Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. , 2006, Assay and drug development technologies.

[51]  E Sullivan,et al.  Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR). , 1999, Methods in molecular biology.

[52]  Tudor I. Oprea,et al.  Flow cytometry for high-throughput, high-content screening. , 2004, Current opinion in chemical biology.

[53]  James Inglese,et al.  Chemokine receptor-ligand interactions measured using time-resolved fluorescence. , 1998, Biochemistry.

[54]  V. Warren,et al.  Functional assay of voltage-gated sodium channels using membrane potential-sensitive dyes. , 2004, Assay and drug development technologies.

[55]  A. Dubin,et al.  Identifying Modulators of hERG Channel Activity Using the PatchXpress® Planar Patch Clamp , 2005, Journal of biomolecular screening.

[56]  Marc K. Halushka,et al.  Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome , 2006, Science.

[57]  C. Jonsson,et al.  Development and Application of a High-Throughput Screening Assay for HIV-1 Integrase Enzyme Activities , 2005, Journal of biomolecular screening.

[58]  R. Gellibolian,et al.  Homogeneous Assays for Cellular Protein Degradation Using β-Galactosidase Complementation: NF-κB/IκB Pathway Signaling , 2003 .

[59]  M. Ferrer,et al.  Miniaturizable homogenous time-resolved fluorescence assay for carboxypeptidase B activity. , 2003, Analytical biochemistry.

[60]  Andreas Sewing,et al.  Fluorescence readouts in HTS: no gain without pain? , 2003, Drug discovery today.

[61]  D. Plant,et al.  High-Throughput Screening of RNA Polymerase Inhibitors Using a Fluorescent UTP Analog , 2006, Journal of biomolecular screening.

[62]  Daniela Gabriel,et al.  High throughput screening technologies for direct cyclic AMP measurement. , 2003, Assay and drug development technologies.

[63]  J. Sever.  Application of a microtechnique to viral serological investigations. , 1962, Journal of immunology.

[64]  G. Rishton.  Nonleadlikeness and leadlikeness in biochemical screening. , 2003, Drug discovery today.

[65]  Ralph Weissleder,et al.  Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. , 2006, RNA.

[66]  James Inglese,et al.  Ligand-receptor binding measured by laser-scanning imaging. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  Paul B Bennett,et al.  High throughput ion-channel pharmacology: planar-array-based voltage clamp. , 2003, Assay and drug development technologies.

[68]  P. So,et al.  Multi-photon excitation of intrinsic protein fluorescence and its application to pharmaceutical drug screening. , 2005, Assay and drug development technologies.

[69]  W. Windsor,et al.  A continuous spectrophotometric assay for the hepatitis C virus serine protease. , 1999, Analytical biochemistry.

[70]  M. Crouch,et al.  GPCR Screening via ERK 1/2: A Novel Platform for Screening G Protein–Coupled Receptors , 2005, Journal of biomolecular screening.

[71]  H. Hakala,et al.  Caspase multiplexing: simultaneous homogeneous time-resolved quenching assay (TruPoint) for caspases 1, 3, and 6. , 2004, Analytical biochemistry.

[72]  Kristiina Vuori,et al.  Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors. , 2007, Journal of medicinal chemistry.

[73]  P. Wipf,et al.  Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors. , 2007, Assay and drug development technologies.

[74]  Christine Williams,et al.  cAMP detection methods in HTS: selecting the best from the rest , 2004, Nature Reviews Drug Discovery.

[75]  E. M. de Groene,et al.  Comparison of 3 AT1 Receptor Binding Assays: Filtration Assay, ScreenReady™ Target, and WGA Flashplate® , 2005, Journal of biomolecular screening.

[76]  S. Mackem,et al.  A Glucocorticoid/Retinoic Acid Receptor Chimera That Displays Cytoplasmic/Nuclear Translocation in Response to Retinoic Acid , 2001, The Journal of Biological Chemistry.

[77]  R. Rigler,et al.  Fluorescence correlation spectroscopy , 2001 .

[78]  C. Plumpton,et al.  A cell-based time-resolved fluorescence assay for selection of antibody reagents for G protein-coupled receptor immunohistochemistry. , 2004, Journal of immunological methods.

[79]  T. Parsons,et al.  Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase. , 2006, Assay and drug development technologies.

[80]  J. Lahiri,et al.  G protein-coupled receptor microarrays for drug discovery. , 2003, Drug discovery today.

[81]  Gregory J. Parker,et al.  Development of High Throughput Screening Assays Using Fluorescence Polarization: Nuclear Receptor-Ligand-Binding and Kinase/Phosphatase Assays , 2000, Journal of biomolecular screening.

[82]  D. Farley,et al.  Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity. , 2003, Assay and drug development technologies.

[83]  Kevin J. Lumb,et al.  High-Throughput Screening by Mass Spectrometry: Comparison with the Scintillation Proximity Assay with a Focused-File Screen of AKT1/PKBα , 2007 .

[84]  Adrian Saldanha,et al.  Structural basis for the spectral difference in luciferase bioluminescence , 2006, Nature.

[85]  E. Kostenis.  Is Gα16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors? , 2001 .

[86]  Huimin Tao,et al.  Automated tight seal electrophysiology for assessing the potential hERG liability of pharmaceutical compounds. , 2004, Assay and drug development technologies.

[87]  Robert J Gillies,et al.  Lanthanide-based luminescent assays for ligand-receptor interactions. , 2005, Life sciences.

[88]  Christine C. Hudson,et al.  The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. , 2002, Assay and drug development technologies.

[89]  B. K. Lundholt,et al.  Identification of RAS-Mitogen-Activated Protein Kinase Signaling Pathway Modulators in an ERF1 Redistribution® Screen , 2006, Journal of biomolecular screening.

[90]  M. S. Ozers,et al.  Development of a coactivator displacement assay for the orphan receptor estrogen-related receptor-gamma using time-resolved fluorescence resonance energy transfer. , 2006, Analytical biochemistry.

[91]  G. Zhou,et al.  Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation. , 2001, Methods.

[92]  Randy Hoffman,et al.  Overcoming compound interference in fluorescence polarization-based kinase assays using far-red tracers. , 2004, Assay and drug development technologies.

[93]  A. Pope,et al.  Simple Absorbance-Based Assays for Ultra-High Throughput Screening , 2001, Journal of biomolecular screening.

[94]  R. Heim,et al.  Development and Application of a GFP-FRET Intracellular Caspase Assay for Drug Screening , 2000, Journal of biomolecular screening.

[95]  B. Alpha-Bazin,et al.  A Homogeneous Caspase-3 Activity Assay Using HTRF® Technology , 2002, Journal of biomolecular screening.

[96]  Jörg Huwyler,et al.  Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery. , 2003, Journal of medicinal chemistry.

[97]  K. Fendler,et al.  Transporter assays using solid supported membranes: a novel screening platform for drug discovery. , 2006, Assay and drug development technologies.

[98]  P. Oberg,et al.  Biosensing of opioids using frog melanophores. , 2002, Biosensors & bioelectronics.

[99]  J. Lemm,et al.  Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay , 2005, Antimicrobial Agents and Chemotherapy.

[100]  Mingsheng Zhang,et al.  Ubistatins Inhibit Proteasome-Dependent Degradation by Binding the Ubiquitin Chain , 2004, Science.

[101]  Maxwell D Cummings,et al.  1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR. , 2005, Bioorganic & medicinal chemistry letters.

[102]  Matthew A Cooper,et al.  Non-optical screening platforms: the next wave in label-free screening? , 2006, Drug discovery today.

[103]  Matthew A Cooper,et al.  Direct quantification of analyte concentration by resonant acoustic profiling. , 2005, Clinical chemistry.

[104]  S. Bandyopadhyay,et al.  A High-Throughput Drug Screen Targeted to the 5'Untranslated Region of Alzheimer Amyloid Precursor Protein mRNA , 2006, Journal of biomolecular screening.

[105]  Terry Kenakin,et al.  A guide to drug discovery: Predicting therapeutic value in the lead optimization phase of drug discovery , 2003, Nature Reviews Drug Discovery.

[106]  Zhengrong Zhu,et al.  Correlation of High-Throughput Pregnane X Receptor (PXR) Transactivation and Binding Assays , 2004, Journal of biomolecular screening.

[107]  A. Verkman.  Drug discovery in academia. , 2004, American journal of physiology. Cell physiology.

[108]  D. Waddleton,et al.  Development of a time-resolved fluorescent assay for measuring tyrosine-phosphorylated proteins in cells. , 2002, Analytical biochemistry.

[109]  Sandra Fox,et al.  High-Throughput Screening: Update on Practices and Success , 2006, Journal of biomolecular screening.

[110]  Xiaocun Chen,et al.  Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy. , 2005, Human molecular genetics.

[111]  D. Weiner,et al.  Integrative functional assays, chemical genomics and high throughput screening: harnessing signal transduction pathways to a common HTS readout. , 2006, Current pharmaceutical design.

[112]  T. Hug,et al.  Biophysical methods for monitoring cell-substrate interactions in drug discovery. , 2003, Assay and drug development technologies.

[113]  S. Fricker,et al.  The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5. , 2005, Assay and drug development technologies.

[114]  R. Eglen,et al.  A homogeneous cell-based assay to measure nuclear translocation using beta-galactosidase enzyme fragment complementation. , 2006, Assay and drug development technologies.

[115]  M. Billah,et al.  A Scintillation Proximity Assay for Human Interleukin-5 (hIL-5) High-Affinity Binding in Insect Cells Coexpressing hIL-5 Receptor α and β Subunits , 1999 .

[116]  O. Civelli,et al.  High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels. , 2003, European journal of pharmacology.

[117]  M. Kennedy,et al.  Measuring human beta-secretase (BACE1) activity using homogeneous time-resolved fluorescence. , 2003, Analytical biochemistry.

[118]  C. Marshall,et al.  Identification of Inhibitors of the Kinase Activity of Oncogenic V600EBRAF in an Enzyme Cascade High-Throughput Screen , 2006, Journal of biomolecular screening.

[119]  L. Kuo,et al.  A Collaborative Screening Program for the Discovery of Inhibitors of HCV NS2/3 cis-Cleaving Protease Activity , 2002, Journal of biomolecular screening.

[120]  G. Prendergast.  Molecular cancer therapeutics : strategies for drug discovery and development , 2005 .

[121]  L. Chee,et al.  Characterization of the kinase domain of the ephrin-B3 receptor tyrosine kinase using a scintillation proximity assay. , 2003, Assay and drug development technologies.

[122]  L. Mitnaul,et al.  Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptors. , 2003, Assay and drug development technologies.

[123]  R. Eglen,et al.  A Generic, Homogenous Method for Measuring Kinase and Inhibitor Activity via Adenosine 5′-Diphosphate Accumulation , 2006, Journal of biomolecular screening.

[124]  F. Fan,et al.  Bioluminescent assays for high-throughput screening. , 2007, Assay and drug development technologies.

[125]  A. Joly,et al.  Identification of small molecule ceramide kinase inhibitors using a homogeneous chemiluminescence high throughput assay. , 2007, Assay and drug development technologies.

[126]  J. Brandts,et al.  An autosampling differential scanning calorimeter instrument for studying molecular interactions. , 2002, Assay and drug development technologies.

[127]  Bruce S Edwards,et al.  Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform , 2006, Nature Protocols.

[128]  M. Cull,et al.  Fluorometric assay for DNA polymerases and reverse transcriptase. , 1996, BioTechniques.

[129]  Xiaoling Xie,et al.  Application of NMR screening in drug discovery. , 2003, Current topics in medicinal chemistry.

[130]  Alan Finkel,et al.  Population Patch Clamp Improves Data Consistency and Success Rates in the Measurement of Ionic Currents , 2006, Journal of biomolecular screening.

[131]  S. Lippard,et al.  Visualization of nitric oxide in living cells by a copper-based fluorescent probe , 2006, Nature chemical biology.

[132]  Xiao Xu,et al.  Live cell quality control and utility of real-time cell electronic sensing for assay development. , 2006, Assay and drug development technologies.

[133]  The Application of Fluorescence Lifetime Readouts in High-Throughput Screening , 2006, Journal of biomolecular screening.

[134]  B. Strulovici,et al.  Miniaturization of a hepatitis C virus RNA polymerase assay using a -102 degrees C cooled CCD camera-based imaging system. , 2001, Analytical biochemistry.

[135]  J. Hermes,et al.  Use of a phosphotyrosine-antibody pair as a general detection method in homogeneous time-resolved fluorescence: application to human immunodeficiency viral protease. , 1999, Analytical biochemistry.

[136]  S. Gellman,et al.  A fluorescence polarization assay for the identification of inhibitors of the p53-DM2 protein-protein interaction. , 2002, Analytical biochemistry.

[137]  E. Boles,et al.  Characterisation of Mammalian GLUT Glucose Transporters in a Heterologous Yeast Expression System , 2003, Cellular Physiology and Biochemistry.

[138]  M. Detheux,et al.  Aequorin-based functional assays for G-protein-coupled receptors, ion channels, and tyrosine kinase receptors. , 2002, Receptors & channels.

[139]  Oleg Kornienko,et al.  Ultra-high-throughput screening for antagonists of a Gi-coupled receptor in a 2.2-microl 3,456-well plate format cyclicAMP assay. , 2007, Assay and drug development technologies.

[140]  Rebecca L Rich,et al.  Higher-throughput, label-free, real-time molecular interaction analysis. , 2007, Analytical biochemistry.

[141]  Jennifer Y. Lee,et al.  Oncology Drug Discovery Applications Using the FMAT™ 8100 HTS System , 2003, Journal of biomolecular screening.

[142]  Ji-Hu Zhang,et al.  Further Comparison of Primary Hit Identification by Different Assay Technologies and Effects of Assay Measurement Variability , 2005, Journal of biomolecular screening.

[143]  H. Fraga,et al.  Thermostable red and green light-producing firefly luciferase mutants for bioluminescent reporter applications. , 2007, Analytical biochemistry.

[144]  S. Millis,et al.  Development and validation of a fluorescence technology for both primary and secondary screening of kinases that facilitates compound selectivity and site-specific inhibitor determination. , 2004, Assay and drug development technologies.

[145]  T. Issad,et al.  The use of bioluminescence resonance energy transfer for the study of therapeutic targets: application to tyrosine kinase receptors , 2007, Expert opinion on therapeutic targets.

[146]  L. Chee,et al.  Development of a high-throughput assay for two inositol-specific phospholipase Cs using a scintillation proximity format. , 2003, Assay and drug development technologies.

[147]  Michael Dean,et al.  A High-Throughput Cell-Based Assay for Inhibitors of ABCG2 Activity , 2006, Journal of biomolecular screening.

[148]  Jeffrey H Toney,et al.  A "mix and read" assay for insulin using fluorometric microvolume assay technology. , 2003, Assay and drug development technologies.

[149]  D. Cully,et al.  A high-throughput assay for modulators of ligand-gated chloride channels. , 2005, Assay and drug development technologies.

[150]  Gregory T O'Donnell,et al.  Miniaturization of absorbance assays using the fluorescent properties of white microplates. , 2005, Analytical biochemistry.

[151]  Dawoon Jung,et al.  NMR-based techniques in the hit identification and optimisation processes , 2004, Expert opinion on therapeutic targets.

[152]  R. Cummings,et al.  Development of a high-capacity homogeneous fluorescent assay for the measurement of leukotriene B4. , 2006, Analytical biochemistry.

[153]  Ming-Wei Wang,et al.  A robust homogeneous binding assay for α4β2 nicotinic acetylcholine receptor , 2005, Acta Pharmacologica Sinica.

[154]  P. Chatelain,et al.  Comparative Study of Membrane Potential-Sensitive Fluorescent Probes and their Use in Ion Channel Screening Assays , 2003, Journal of biomolecular screening.

[155]  Rory Curtis,et al.  A Novel Membrane Potential-Sensitive Fluorescent Dye Improves Cell-Based Assays for Ion Channels , 2002, Journal of biomolecular screening.

[156]  James Inglese,et al.  Development of an intact cell reporter gene beta-lactamase assay for G protein-coupled receptors for high-throughput screening. , 2003, Analytical biochemistry.

[157]  J. Sportsman,et al.  Immobilized metal ion affinity-based fluorescence polarization (IMAP): advances in kinase screening. , 2004, Assay and drug development technologies.

[158]  L. Makings,et al.  A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases. , 2002, Assay and drug development technologies.

[159]  G. Zlokarnik.  [15] Fusions to β-lactamase as a reporter for gene expression in live mammalian cells , 2000 .

[160]  D. Fairlie,et al.  Protease inhibitors: current status and future prospects. , 2000, Journal of medicinal chemistry.

[161]  J. Doughty,et al.  Development of a High-Throughput Screening Assay for Inhibitors of Aggrecan Cleavage Using Luminescent Oxygen Channeling (AlphaScreen™) , 2003, Journal of biomolecular screening.

[162]  B. Strulovici,et al.  Miniaturization of Intracellular Calcium Functional Assays to 1536-Well Plate Format Using a Fluorometric Imaging Plate Reader , 2004, Journal of biomolecular screening.

[163]  Christian N Parker,et al.  Inhibition Profiling of Human Carbonic Anhydrase II by High-Throughput Screening of Structurally Diverse, Biologically Active Compounds , 2006, Journal of biomolecular screening.

[164]  E. Trinquet,et al.  Fluorescence technologies for the investigation of chemical libraries. , 2006, Molecular bioSystems.

[165]  Christopher P Austin,et al.  A high-throughput screen for aggregation-based inhibition in a large compound library. , 2007, Journal of medicinal chemistry.

[166]  K. Pearce,et al.  Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. , 2001, Cytometry.

[167]  A. Smith,et al.  A scintillation proximity assay for the Raf/MEK/ERK kinase cascade: high-throughput screening and identification of selective enzyme inhibitors. , 1999, Analytical biochemistry.

[168]  M. Lohse,et al.  Receptor-Ligand Interactions Studied with Homogeneous Fluorescence-Based Assays Suitable for Miniaturized Screening , 2001, Journal of biomolecular screening.

[169]  Adel Bakhtiarova,et al.  Resveratrol inhibits firefly luciferase. , 2006, Biochemical and biophysical research communications.

[170]  James Inglese,et al.  A cell-based β-lactamase reporter gene assay for the identification of inhibitors of hepatitis C virus replication , 2004 .

[171]  Edward M. Goldberg,et al.  Homogeneous Cell- and Bead-Based Assays for High Throughput Screening Using Fluorometric Microvolume Assay Technology , 1999, Journal of biomolecular screening.

[172]  E. F. Ullman,et al.  Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[173]  G. Zaman,et al.  Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitors. , 2006, Assay and drug development technologies.

[174]  J. Hartman,et al.  High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds. , 2007, Assay and drug development technologies.

[175]  K. Zeh,et al.  Gain-of-function somatic cell lines for drug discovery applications generated by homologous recombination. , 2003, Assay and drug development technologies.

[176]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[177]  D. Wirth,et al.  High-Throughput Plasmodium falciparum Growth Assay for Malaria Drug Discovery , 2006, Antimicrobial Agents and Chemotherapy.

[178]  I. Davydov,et al.  Assays for high-throughput screening of E2 AND E3 ubiquitin ligases. , 2005, Methods in enzymology.

[179]  M. Ferrer,et al.  A β-Lactamase-Dependent Gal4-Estrogen Receptor β Transactivation Assay for the Ultra-High Throughput Screening of Estrogen Receptor β Agonists in a 3,456-Well Format , 2003 .

[180]  L A Sklar,et al.  High throughput screening of G-protein coupled receptors via flow cytometry. , 2003, Combinatorial chemistry & high throughput screening.

[181]  Kim E. Garbison,et al.  The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies , 2006, Journal of biomolecular screening.

[182]  G. Milligan,et al.  CypHer 5: a generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. , 2003, Assay and drug development technologies.

[183]  Robert W. Bryant,et al.  Evaluation of Fluorescent Compound Interference in 4 Fluorescence Polarization Assays: 2 Kinases, 1 Protease, and 1 Phosphatase , 2003, Journal of biomolecular screening.

[184]  J Fraser Glickman,et al.  Comparison of Assay Technologies for a Nuclear Receptor Assay Screen Reveals Differences in the Sets of Identified Functional Antagonists , 2003, Journal of biomolecular screening.

[185]  J. Olefsky,et al.  Nuclear Receptor Minireview Series* , 2001, The Journal of Biological Chemistry.

[186]  M. Gehring,et al.  Assay development and data analysis of receptor-ligand binding based on scintillation proximity assay. , 2005, Metabolic engineering.

[187]  Meenal Patel,et al.  PTC124 targets genetic disorders caused by nonsense mutations , 2007, Nature.

[188]  James R Beasley,et al.  Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays. , 2004, Assay and drug development technologies.

[189]  Shane D. Marine,et al.  A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation. , 2006, Analytical biochemistry.

[190]  J. Lakowicz.  Principles of fluorescence spectroscopy , 1983 .

[191]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[192]  R. Cummings,et al.  Development of Novel Assays for Proteolytic Enzymes Using Rhodamine-Based Fluorogenic Substrates , 2002, Journal of biomolecular screening.

[193]  Igor L. Medintz,et al.  Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.

[194]  R. Tsien,et al.  The Fluorescent Toolbox for Assessing Protein Location and Function , 2006, Science.

[195]  Christian Eggeling,et al.  Experiences in implementing uHTS--cutting edge technology meets the real world. , 2004, Current drug discovery technologies.

[196]  T. Widlanski,et al.  An Intuitive Look at the Relationship of Ki and IC50: A More General Use for the Dixon Plot , 2003 .

[197]  Yaolin Wang,et al.  Fluorescence polarization assay and inhibitor design for MDM2/p53 interaction. , 2004, Analytical biochemistry.

[198]  A K Chakraborty,et al.  Origin of nanomechanical cantilever motion generated from biomolecular interactions. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[199]  R. Eglen,et al.  Beta galactosidase enzyme fragment complementation as a novel technology for high throughput screening. , 2003, Combinatorial chemistry & high throughput screening.

[200]  G. Guella,et al.  A fluorescence-based assay for the reductase activity of protein disulfide isomerase. , 2006, Analytical biochemistry.

[201]  G. Terstappen.  Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. , 2004, Assay and drug development technologies.

[202]  Horst Wallrabe,et al.  Imaging protein molecules using FRET and FLIM microscopy. , 2005, Current opinion in biotechnology.

[203]  J. Glickman,et al.  Characterization of fatty acid synthase activity using scintillation proximity. , 2003, Assay and drug development technologies.

[204]  K. Oldenburg,et al.  A high-throughput homogeneous assay for reverse transcriptase using generic reagents and time-resolved fluorescence detection. , 2000, Analytical biochemistry.

[205]  Jörg Hüser,et al.  A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway. , 2005, Analytical biochemistry.

[206]  A. Young,et al.  A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[207]  Noel Southall,et al.  A Cell-Based Assay for IκBα Stabilization Using A Two-Color Dual Luciferase-Based Sensor , 2007 .

[208]  J. Lamerdin,et al.  Measuring drug action in the cellular context using protein-fragment complementation assays. , 2003, Assay and drug development technologies.

[209]  G Ulrich Nienhaus,et al.  Confocal fluorescence microscopy for high-throughput screening of G-protein coupled receptors. , 2005, Current medicinal chemistry.

[210]  A. Cochran,et al.  Substrate capacity considerations in developing kinase assays. , 2004, Assay and drug development technologies.

[211]  D. Wicks,et al.  Atomic absorption spectroscopy in ion channel screening. , 2004, Assay and drug development technologies.

[212]  Y. Kuryshev,et al.  HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk. , 2005, Journal of pharmacological and toxicological methods.

[213]  R. Eglen,et al.  Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening. , 2007, Assay and drug development technologies.

[214]  Claudio Dalvit,et al.  NMR screening techniques in drug discovery and drug design , 2002 .

[215]  Xiao Xu,et al.  Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors. , 2006, Analytical chemistry.

[216]  Kenneth A. Giuliano,et al.  High Content Screening , 2006 .

[217]  Steven W Graves,et al.  Microsphere‐based protease assays and screening application for lethal factor and factor Xa , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[218]  E E Swartzman,et al.  A homogeneous and multiplexed immunoassay for high-throughput screening using fluorometric microvolume assay technology. , 1999, Analytical biochemistry.

[219]  P. Leff,et al.  Further concerns over Cheng-Prusoff analysis. , 1993, Trends in pharmacological sciences.

[220]  W. Link,et al.  An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. , 2007, Assay and drug development technologies.

[221]  N. Thomas,et al.  Dynamic green fluorescent protein sensors for high-content analysis of the cell cycle. , 2006, Methods in enzymology.

[222]  Maxwell D Cummings,et al.  Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells. , 2005, Journal of medicinal chemistry.

[223]  P. Huang,et al.  Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence. , 2000, Analytical biochemistry.

[224]  Y. Liu,et al.  Novel functional assay for proteases and modulators , 2001, Molecular biotechnology.

[225]  T. Pawson,et al.  Protein phosphorylation in signaling--50 years and counting. , 2005, Trends in biochemical sciences.

[226]  Christopher P Austin,et al.  Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate format. , 2006, Methods in enzymology.

[227]  R. Larsson,et al.  Image-Based Screening for the Identification of Novel Proteasome Inhibitors , 2007, Journal of biomolecular screening.

[228]  S. Michnick,et al.  Mapping biochemical networks with protein-fragment complementation assays. , 2004, Methods in molecular biology.

[229]  Christine C. Hudson,et al.  Automation and validation of the Transflour technology: a universal screening assay for G protein-coupled receptors , 2002, SPIE BiOS.

[230]  M. Valler,et al.  Evaluation of the InteraX™ System Technology in a High-Throughput Screening Environment , 2005, Journal of biomolecular screening.

[231]  R. Seethala,et al.  A Homogeneous Enzyme Fragment Complementation Cyclic AMP Screen for GPCR Agonists , 2002, Journal of biomolecular screening.

[232]  Susan M. Young,et al.  Duplexed, bead‐based competitive assay for inhibitors of protein kinases , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[233]  C. Contag,et al.  Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release. , 2006, Journal of the American Chemical Society.

[234]  J. Jungmann,et al.  Early Identification of False Positives in High-Throughput Screening for Activators of p53-DNA Interaction , 2006, Journal of biomolecular screening.

[235]  U. Warrior,et al.  Functional analysis of large conductance Ca2(+)-activated K(+) channels: ion flux studies by atomic absorption spectrometry. , 2003, Assay and drug development technologies.

[236]  Victor S. Lobanov,et al.  High-Density Miniaturized Thermal Shift Assays as a General Strategy for Drug Discovery , 2001 .

[237]  Michel Bouvier,et al.  Pharmacological chaperones: potential treatment for conformational diseases , 2004, Trends in Endocrinology & Metabolism.

[238]  U. Haupts,et al.  Single-Molecule Detection Technologies in Miniaturized High Throughput Screening: Binding Assays for G Protein-Coupled Receptors Using Fluorescence Intensity Distribution Analysis and Fluorescence Anisotropy , 2001, Journal of biomolecular screening.

[239]  Matthew A Cooper,et al.  Quantification of small molecule-receptor affinities and kinetics by acoustic profiling. , 2006, Assay and drug development technologies.

[240]  W. Blair,et al.  A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors. , 2005, Antiviral research.

[241]  Kewei Wang,et al.  Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000. , 2004, Assay and drug development technologies.

[242]  T. Turek-Etienne,et al.  Development of a fluorescence polarization AKT serine/threonine kinase assay using an immobilized metal ion affinity-based technology. , 2003, Assay and drug development technologies.

[243]  J. P. Hobson,et al.  Imaging specific cell-surface proteolytic activity in single living cells , 2006, Nature Methods.

[244]  G. Terstappen,et al.  A continuous time-resolved fluorescence assay for identification of BACE1 inhibitors. , 2005, Assay and drug development technologies.

[245]  I. Hemmilä,et al.  Progress in Lanthanides as Luminescent Probes , 2005, Journal of Fluorescence.

[246]  G. Zlokarnik,et al.  Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. , 1998, Science.

[247]  I. Johnson,et al.  Chemical and physiological characterization of fluo-4 Ca(2+)-indicator dyes. , 2000, Cell calcium.

[248]  E. Swartzman,et al.  Determination of ligand binding affinities for endogenous seven-transmembrane receptors using fluorometric microvolume assay technology. , 1999, Analytical biochemistry.

[249]  D. Steinhilber,et al.  Molecular biology in medicinal chemistry , 2004 .

[250]  M. Manoharan,et al.  Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. , 2001, Nucleic acids research.

[251]  Pascale G. Charest,et al.  Monitoring agonist‐promoted conformational changes of β‐arrestin in living cells by intramolecular BRET , 2005, EMBO reports.

[252]  Paul McCoy,et al.  1,536-well assay development and screening using whole cell displacement binding and laser scanning imaging. , 2003, Assay and drug development technologies.

[253]  K. Crane,et al.  Development of a homogeneous binding assay for histamine receptors. , 2004, Analytical biochemistry.

[254]  Andreas Sewing,et al.  Measuring intracellular calcium fluxes in high throughput mode. , 2003, Combinatorial chemistry & high throughput screening.

[255]  A. Kral,et al.  Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors , 2022 .

[256]  E. May,et al.  Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract. , 2002, Analytical biochemistry.

[257]  J Fraser Glickman,et al.  A Comparison of ALPHAScreen, TR-FRET, and TRF as Assay Methods for FXR Nuclear Receptors , 2002, Journal of biomolecular screening.

[258]  J. Pelletier,et al.  High-Throughput Screening of G Protein-Coupled Receptor Antagonists Using a Bioluminescence Resonance Energy Transfer 1-Based β-Arrestin2 Recruitment Assay , 2005, Journal of biomolecular screening.

[259]  R. Kriz,et al.  Development and comparison of nonradioactive in vitro kinase assays for NIMA-related kinase 2. , 2006, Analytical biochemistry.

[260]  Sikander Gill,et al.  Development of an HTS assay for Na+, K+-ATPase using nonradioactive rubidium ion uptake. , 2004, Assay and drug development technologies.

[261]  Peter Banks,et al.  Considerations for Using Fluorescence Polarization in the Screening of G Protein-Coupled Receptors , 2002, Journal of biomolecular screening.

[262]  Robert H Gallavan,et al.  Evaluation of the rubidium efflux assay for preclinical identification of HERG blockade. , 2006, Assay and drug development technologies.

[263]  J. Wölcke,et al.  Miniaturized HTS technologies - uHTS. , 2001, Drug discovery today.

[264]  S. Tunaru,et al.  Comparative Analysis of Functional Assays for Characterization of Agonist Ligands at G Protein-Coupled Receptors , 2003, Journal of biomolecular screening.

[265]  Jesús E González,et al.  Cellular fluorescent indicators and voltage/ion probe reader (VIPR) tools for ion channel and receptor drug discovery. , 2002, Receptors & channels.

[266]  James Inglese.  Measuring biological responses with automated microscopy , 2006 .

[267]  G. Zaman,et al.  High-throughput screening with immobilized metal ion affinity-based fluorescence polarization detection, a homogeneous assay for protein kinases. , 2003, Assay and drug development technologies.

[268]  G. Zaman,et al.  High-Throughput Screening Using β-Lactamase Reporter-Gene Technology for Identification of Low-Molecular-Weight Antagonists of the Human Gonadotropin Releasing Hormone Receptor , 2005 .

[269]  M. Ferrer,et al.  A 1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation. , 2004, Assay and drug development technologies.

[270]  Y. Z. Chen,et al.  Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics , 2006, Pharmacological Reviews.

[271]  M. Ferrer,et al.  A fully automated [35S]GTPgammaS scintillation proximity assay for the high-throughput screening of Gi-linked G protein-coupled receptors. , 2003, Assay and drug development technologies.

[272]  Brian J Eastwood,et al.  A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z' Factor, and Assay Variability Ratio , 2006, Journal of biomolecular screening.